Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Efsubaglutide Alfa

The Efficacy and Safety of Efsubaglutide Alfa in Overweight/Obesity(SPARKLE)

Shanghai Yinnuo Pharmaceutical Technology Co · Phase 2 · Recruiting · Enrollment 200

NCT07114419

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Efsubaglutide 20 mg Quaque Week (QW)n/rn/rn/rn/rn/r
Efsubaglutide 40 mg QWn/rn/rn/rn/rn/r
Efsubaglutide Alfa 40 mg Q2Wn/rn/rn/rn/rn/r
Efsubaglutide Alfa 80 mg QWn/rn/rn/rn/rn/r
Efsubaglutide Alfa 80 mg Q4Wn/rn/rn/rn/rn/r

A count stays a count. This page does not turn a count into a percent.